SCT Annual Meeting Presentations & Videos

Discover SCT's Scientific Knowledge-Bank

  261 Learning Opportunities Found

Richard Stephens
2016 (Montreal) Annual Meeting
Founders Lecture
Patients as Partners in Cancer Research
LEAP Trial team
2016 (Montreal) Annual Meeting
Trial of the Year Award
Learning Early About Peanut Allergy (LEAP)
Wendy Parulekar
2016 (Montreal) Annual Meeting
Presidential Welcome
Denis Lacombe
2016 (Montreal) Annual Meeting
Curtis Meinert Lecture
EOTRC (European Organisation for Research and Treatment of Cancer)
Mark Espeland
2016 (Montreal) Annual Meeting
Fellows Presentation
Presentation of the Class of 2016 Fellows
Professor Paula Williamson
2016 (Montreal) Annual Meeting
Invited Session
"Improving health by improving trials" – the UK Medical Research Council (MRC) Hubs for Trials Methodology Research (HTMR): a nation-wide network to develop capacity and optimise trial design and conduct
Professor Barney Reeves
2016 (Montreal) Annual Meeting
Invited Session
“It’s always too early until suddenly it’s too late”: designing surgical RCTs relevant to patients, staff and changing technologies
Haitao Pan
2016 (Montreal) Annual Meeting
Contributed Session
A Bayesian Adaptive Group Sequential Design for Biosimilars with Historical Data
Catherine Oldenburg
2016 (Montreal) Annual Meeting
Contributed Session
A CASE FOR CACE: THE COMPLIER AVERAGE CAUSAL EFFECT IN RANDOMIZED CONTROLLED TRIALS
Michael Palmer
2016 (Montreal) Annual Meeting
Contributed Session
A Classification Framework For Root Causes Of Missing Data With Patient Reported Outcomes In Prospective Studies
Geetha Beauchamp
2016 (Montreal) Annual Meeting
Contributed Session
A CLUSTER RANDOMIZED ANALYSIS OF SITE-LEVEL HIV SURVEILLANCE DATA IN HPTN 065 (TLC-PLUS) STUDY
Paula Darby Lipman
2016 (Montreal) Annual Meeting
Contributed Session
A COLLABORATIVE STRATEGY TO CONDUCT AND LEARN FROM HIGH IMPACT PRAGMATIC TRIALS
Nathaniel O'Connell
2016 (Montreal) Annual Meeting
Contributed Session
A latent variable approach to elicit continuous toxicity scores and severity weights for multiple toxicities in cancer clinical trials
Mohamed-Amine Bayar
2016 (Montreal) Annual Meeting
Contributed Session
A long-term horizon simulation study to guide time-to-event RCTs with interim analyses in rare diseases
Eric Tustison
2016 (Montreal) Annual Meeting
Contributed Session
A Nested Query Method for Efficient Enforcement of Timely Data Entry for Scheduled Outcomes
Laura Collett
2016 (Montreal) Annual Meeting
Contributed Session
A NOVEL METHOD FOR ADJUSTING SURVIVAL ANALYSES TO REMOVE THE CONFOUNDING EFFECTS OF SUBSEQUENT THERAPY (CASCADE)
David M. Murray
2016 (Montreal) Annual Meeting
Invited Session
A practical overview of missing data issues in cluster-randomized designs for pragmatic trials
Martin Tickle
2016 (Montreal) Annual Meeting
Contributed Session
A randomised control trial to measure the effects and costs of a dental caries prevention regime for young children attending primary care dental services (Northern Ireland Caries Prevention In Practice Trial - NIC-PIP trial)
Alan Girling
2016 (Montreal) Annual Meeting
Contributed Session
A restricted randomisation scheme for stepped-wedge studies with a cluster-level covariate
Cole Wayant
2016 (Montreal) Annual Meeting
Contributed Session
A review of outcomes presented in published and unpublished studies of pediatric acute lymphoblastic leukemia: Toward the development of a core outcome set.
Yaoyao Xu
2016 (Montreal) Annual Meeting
Contributed Session
A Seamless Phase 2/3 Design Based on Continuous Outcome
Soe Soe Thwin
2016 (Montreal) Annual Meeting
Contributed Session
A simple approach to assess enrollment prediction in clinical trials
Allan Walker
2016 (Montreal) Annual Meeting
Contributed Session
A smarter stock re-supply mechanism for multi-centre drug trials where participants are prescribed drugs at multiple visits - an example from the MS-SMART trial
Matthew Sims
2016 (Montreal) Annual Meeting
Contributed Session
A SYTEMATIC REVIEW OF CORE DOMAIN AND OUTCOME MEASUREMENT FOR SHOULDER ARTHROPLASTY TRIALS
Kevin Wilson
2016 (Montreal) Annual Meeting
Contributed Session
A Tool to Generate and Validate Permuted-Block Randomization Tables
Graham Wheeler
2016 (Montreal) Annual Meeting
Contributed Session
A toxicity-dependent feasibility bound for the Escalation with Overdose Control approach in phase I cancer trials
Meghan Engbretson
2016 (Montreal) Annual Meeting
Contributed Session
ACADEMIC COOPERATIVE GROUP IMPLEMENTATION OF THE INITIATIVE TO STREAMLINE CLINICAL TRIALS
Ileana Baldi
2016 (Montreal) Annual Meeting
Contributed Session
Accrual monitoring in cardiology research
Neil Corrigan
2016 (Montreal) Annual Meeting
Contributed Session
Adjusting for learning effects in a surgical RCT
DONALD TAVES
2016 (Montreal) Annual Meeting
Contributed Session
Advances in the Minimization vs. Randomization Debate
Avie-Lee Tillotson
2016 (Montreal) Annual Meeting
Contributed Session
Adverse event coding in early phase trials
Yiyi Chen
2016 (Montreal) Annual Meeting
Contributed Session
An Adaptive Bayesian Sequential Design Implemented Through an Interactive Software for Onsite Treatment Assignment
Gennaro De Crescenzo
2016 (Montreal) Annual Meeting
Contributed Session
An efficient and economic solution for a clinical trial - Registry-based Randomized Clinical Trial (RRCT)
Austin Horn
2016 (Montreal) Annual Meeting
Contributed Session
An ethical analysis of the SUPPORT study: Addressing challenges posed by a randomized controlled trial comparing standard treatments used in medical practice.
Rebecca Simpson
2016 (Montreal) Annual Meeting
Contributed Session
AN INVESTIGATION OF THE FACTORS WHICH INFLUENCE CHILDREN WITH ASTHMA HAVING UNSCHEDULED MEDICAL CONTACTS AROUND THE START OF THE NEW SCHOOL YEAR IN ENGLAND AND WALES
Corrado Lanera
2016 (Montreal) Annual Meeting
Contributed Session
ANALYSIS OF FREE TEXT ON ELECTRONIC MEDICAL REPORTS USING SEMI-SUPERVISED MACHINE LEARNING TECHNIQUES: A COMPARATIVE CASE-STUDY ON VARICELLA
Karla Hemming
2016 (Montreal) Annual Meeting
Contributed Session
ANALYSIS OF THE CROSS-SECTIOTIONAL STEPPED WEDGE CLUSTER RANDOMSIED TRIAL
Brittney Bailey
2016 (Montreal) Annual Meeting
Contributed Session
Analyzing Binary Outcome Data from an Individually Randomized Group Treatment Trial
Samantha Hinsley
2016 (Montreal) Annual Meeting
Contributed Session
APPLICATION OF A BAYESIAN APPROACH TO TREATMENT SELECTION IN A RARE DISEASE SUB-POPULATION
James Rochon
2016 (Montreal) Annual Meeting
Contributed Session
APPLICATION OF THE MARGINAL STRUCTURAL MODEL TO ACCOUNT FOR SUBOPTIMAL ADHERENCE IN A RANDOMIZED CONTROLLED TRIAL
Gillian Gresham
2016 (Montreal) Annual Meeting
Contributed Session
Applications of wearable activity monitors in randomized clinical trials (RCT) in chronic disease populations: A review of the literature
Ines Rombach
2016 (Montreal) Annual Meeting
Contributed Session
APPLYING MULTIPLE IMPUTATION TO MULTI-ITEM PATIENT REPORTED OUTCOME MEASURES: ADVANTAGES AND DISADVANTAGES OF IMPUTING AT THE ITEM, SUB-SCALE OR SCORE LEVEL
Raymond Kraker
2016 (Montreal) Annual Meeting
Contributed Session
ARE LESS ACTIVE SITES MORE LIKELY TO DEVIATE FROM STUDY PROTOCOL AND PROCEDURES?
Susan Halabi
2016 (Montreal) Annual Meeting
Contributed Session
Are Prognostic Models Valuable Tools in Guiding Treatment Decisions?
Susan Halabi
2016 (Montreal) Annual Meeting
Invited Session
Are Prognostic Models Valuable Tools in Guiding Treatment Decisions?
Joanna Crocker
2016 (Montreal) Annual Meeting
Contributed Session
Assessing the impact of patient and public involvement on enrolment and retention in clinical trials: a systematic review
Wenle Zhao
2016 (Montreal) Annual Meeting
Contributed Session
ASYMPTOTIC MAXIMAL PROCEDURE FOR SUBJECT RANDOMIZATION
Sam T Mathew
2016 (Montreal) Annual Meeting
Invited Session
Authorship of clinical trial publications. Is there a way to quantify the involvement and provide appropriate credit to the contributors?
Hope Bryan
2016 (Montreal) Annual Meeting
Contributed Session
AUTOMATING THE EVENT REVIEW AND ADJUDICATION PROCESS FOR LARGE LONGITUDINAL STUDIES
Robert Lew
2016 (Montreal) Annual Meeting
Contributed Session
Balancing site characteristics for stepped wedge designs
Catherine Lowe
2016 (Montreal) Annual Meeting
Contributed Session
BEYOND THE PARTICIPANT INFORMATION SHEET: UTILISING PATIENT AND PUBLIC INVOLVEMENT TO IMPROVE PARTICIPANT INFORMATION
Sabine Landau
2016 (Montreal) Annual Meeting
Contributed Session
Beyond total treatment effects in RCTs: Baseline measurement of intermediate outcomes needed to avoid confounding in mediation investigations
Aurore Giljean
2016 (Montreal) Annual Meeting
Contributed Session
BIOMEDE Trial: a European randomized Phase 2 trial based on biomarkers evaluating new drugs in Diffuse Intrinsic Pontine Glioma (DIPG).
Nicola Soriani
2016 (Montreal) Annual Meeting
Contributed Session
BIOSTAPP: AN INTEGRATED REPORTING AND MONITORING SYSTEM FOR CLINICAL STUDIES USING OPEN SOURCE SYSTEM
Robert Califf
2016 (Montreal) Annual Meeting
Invited Session
Building the Clinical Trials Enterprise of the Future
Martina McMenamin
2016 (Montreal) Annual Meeting
Contributed Session
CAUSAL MODELLING IN TRIALS WITH SMALL SAMPLE SIZES
Catherine Dillon
2016 (Montreal) Annual Meeting
Invited Session
Central IRBs: Implementation, Effectiveness, and Optimization
Catherine Dillon
2016 (Montreal) Annual Meeting
Invited Session
Challenges and Solutions to the Coordination and Conduct of an Emergency Treatment Trial
Caitlyn Ellerbe
2016 (Montreal) Annual Meeting
Invited Session
Challenges of Implementing an Adaptive Design in an Academic Network Setting
Dave Shade
2016 (Montreal) Annual Meeting
Contributed Session
CHARACTERIZATION OF DOUBLE-DATA-ENTRY IN DATA ENTRY SYSTEMS EMPLOYING MODERN INTERFACE ELEMENTS.
Erika Cullingford
2016 (Montreal) Annual Meeting
Contributed Session
CLINICAL PROTOCOL DISSECTION: BEST PRACTICES TO REVIEWING A PROTOCOL THROUGH DIFFERENT ROLES AND STAGES FROM THE PERSPECTIVE OF A MULTI-PROJECT CRO
Faye Williamson
2016 (Montreal) Annual Meeting
Contributed Session
Clinical Trial Design for Rare Diseases using Bayesian Bandit Models
Jeannette Lee
2016 (Montreal) Annual Meeting
Contributed Session
Clinical Trial Participation Among HIV-infected Persons with Cancer
Marie-Claude Boily
2016 (Montreal) Annual Meeting
Invited Session
Clinical trial simulations: the when, where and what
Valerie Durkalski
2016 (Montreal) Annual Meeting
Invited Session
Collaborating with Patient Advocacy Groups at the Design Stage of your Clinical Trial, and Why is it so Important
Tracey Davidson
2016 (Montreal) Annual Meeting
Contributed Session
Comparing the feasibility and acceptability of collecting patient reported outcomes using text message and paper diary
Ayodele Odutayo
2016 (Montreal) Annual Meeting
Contributed Session
Comparison of Clinical Trial Protocols and Clinical Trial Registry Entries: A Cross-sectional Study
Nicole Solomon
2016 (Montreal) Annual Meeting
Contributed Session
Comparison of Regression Imputation Methods for the Analysis of Time-to-event Endpoints Subject to Censoring
Kaleab Abebe
2016 (Montreal) Annual Meeting
Contributed Session
Comparison of two Screening Strategies for Gestational Diabetes (GDM2) Trial: Design and Rationale
Ashley Hogan
2016 (Montreal) Annual Meeting
Contributed Session
CONSIDERATIONS AND CHALLENGES FOR TRANSITION TO MOBILE ELECTRONIC PATIENT REPORTED OUTCOMES (ePRO) IN A LONG-TERM TRIAL WITH AN AGING AND DIVERSE POPULATION
Donna Reidlinger
2016 (Montreal) Annual Meeting
Contributed Session
Consumers and the community as true partners in research
Julian Wolfson, PhD
2016 (Montreal) Annual Meeting
Invited Session
Courage, controversy, and clinical trials: Lessons from the Ebola epidemic
Mary Putt, PhD, ScD
2016 (Montreal) Annual Meeting
Invited Session
Crossover Trials: New Perspectives and Practical Implications for an Efficient Design
Jane Perlmutter
2016 (Montreal) Annual Meeting
Contributed Session
CTTI’s Recommendations for Improving Informed Consent
Shaun Treweek
2016 (Montreal) Annual Meeting
Invited Session
Data and Biorepositories: Enhancing Collaborative Science
Leonard Friedman
2016 (Montreal) Annual Meeting
Contributed Session
Data quality management in NeuroBANK; a clinical research data aggregation platform
Doussau Adelaide
2016 (Montreal) Annual Meeting
Contributed Session
DECIPHERING ASSUMPTIONS ABOUT STEPPED WEDGE DESIGNS: THE CASE OF EBOLA VACCINE RESEARCH
Richard Emsley
2016 (Montreal) Annual Meeting
Contributed Session
Design issues in trials of complex and digital interventions
Dr Gillian Lancaster
2016 (Montreal) Annual Meeting
Invited Session
Design, conduct and reporting of pilot and feasibility studies carried out in a health care setting in preparation for a randomised controlled trial testing the effectiveness of a complex intervention
Caroline Brard
2016 (Montreal) Annual Meeting
Contributed Session
Designing a Bayesian randomized controlled trial in osteosarcoma: how to incorporate historical data?
Dikla Shmueli-Blumberg
2016 (Montreal) Annual Meeting
Contributed Session
DEVELOPING A COMPREHENSIVE AND EFFECTIVE PROCESS FOR CLOSING OUT A STUDY: STRATEGIES FROM CLOSING OUT MULTI-SITE SUBSTANCE USE TREATMENT CLINICAL TRIALS
Anne Hoehn
2016 (Montreal) Annual Meeting
Contributed Session
Developing a Data Management Plan for Electronic Medical Records Abstraction within Clinical Trials: A Report from NIDA CTN Studies
Nisha Grover
2016 (Montreal) Annual Meeting
Contributed Session
DEVELOPING A MOBILE-BASED ePRO SYSTEM
Joanna Crocker
2016 (Montreal) Annual Meeting
Contributed Session
Developing a Patient and public Involvement intervention to enhance Recruitment and Retention In UK Surgical Trials (PIRRIST)
Yong Ma; Junshan Qiu
2016 (Montreal) Annual Meeting
Invited Session
Development in Evaluating Cardiovascular Risk: Pre- and Post-marketing
Magda Monreal
2016 (Montreal) Annual Meeting
Contributed Session
DEVELOPMENT OF A COLLABORATIVE APPROACH TO ACCRUAL OF ADOLESCENTS AND YOUNG ADULTS WITH CANCER TO CLINICAL TRIALS IN CANADA: A JOINT REPORT FROM THE PEDIATRIC C17 COUNCIL AND THE ADULT CANADIAN CANCER TRIALS GROUP.
Zachary Sanchez
2016 (Montreal) Annual Meeting
Contributed Session
DEVELOPMENT OF A CORE OUTCOME SET FOR HYPEREMESIS GRAVIDARUM
Gregory Aran
2016 (Montreal) Annual Meeting
Contributed Session
DEVELOPMENT OF A CORE OUTCOME SET FOR PEDIATRIC POSTOPERATIVE PAIN
Dave Shade
2016 (Montreal) Annual Meeting
Contributed Session
DISTRIBUTION OF ITEM TYPES USED IN CASE REPORT FORMS IMPLEMENTED IN MODERN DATA MANAGEMENT SYSTEMS.
Shaun Treweek
2016 (Montreal) Annual Meeting
Contributed Session
Do pragmatic trials trade-off internal validity for external validity?
Michael Grayling
2016 (Montreal) Annual Meeting
Contributed Session
Do single-arm trials have a role in drug development plans incorporating randomised trials?
Nicole C. Close, PhD
2016 (Montreal) Annual Meeting
Invited Session
Don't Be Afraid: Risk Based Monitoring at a Deconstructed Level for Implementation
Erin Gabriel
2016 (Montreal) Annual Meeting
Contributed Session
Early Phase Transmission Blocking Vaccine Trials: Evaluation without Validated Surrogates
Emily V. Dressler
2016 (Montreal) Annual Meeting
Invited Session
Early-Phase Designs for Contemporary Dose-Finding Problems in Oncology
Cynthia L Green & Borje Darpo
2016 (Montreal) Annual Meeting
Invited Session
ECG Assessment in Early Clinical Trials
Aenne Glass
2016 (Montreal) Annual Meeting
Contributed Session
EFFECT OF 10 DIFFERENT POLYMORPHISMS ON PREOPERATIVE VOLUMETRIC CHARACTERISTICS OF GLIOBLASTOMA MULTIFORME - RESULTS OF A PILOT STUDY
Kristen Cunanan
2016 (Montreal) Annual Meeting
Contributed Session
Efficient Basket Trial Designs
Abigail Shoben
2016 (Montreal) Annual Meeting
Contributed Session
Efficient designs for comparing control, treatment, and treatment plus in randomized trials
Steven A. Julious
2016 (Montreal) Annual Meeting
Invited Session
Efficient study designs in clinical research
J Athene Lane
2016 (Montreal) Annual Meeting
Contributed Session
Enhancing patient and public involvement in trial oversight committees through qualitative research with eight large trials facing challenges
Dr. Michael C Sachs
2016 (Montreal) Annual Meeting
Invited Session
Episodic, rare and hard to measure outcomes in infectious diseases: challenges to clinical trial design
Leila Rooshenas
2016 (Montreal) Annual Meeting
Contributed Session
EQUIPOISE IN ACTION: AN INVESTIGATION ACROSS SIX PRAGMATIC RANDOMIZED CONTROLLED TRIALS
Karla Hemming
2016 (Montreal) Annual Meeting
Contributed Session
Establishing an upper bound on the optimal cluster size in cluster randomised trials with a limited number of clusters
Andrew Forbes
2016 (Montreal) Annual Meeting
Contributed Session
Estimation in multiple period cluster randomized trials with non-uniform correlation structure
Dean Fergusson
2016 (Montreal) Annual Meeting
Invited Session
Ethical challenges in pragmatic comparative effectiveness trials
Dean Fergusson
2016 (Montreal) Annual Meeting
Invited Session
Ethical challenges in pragmatic comparative effectiveness trials
Dean Fergusson
2016 (Montreal) Annual Meeting
Invited Session
Ethical challenges in pragmatic comparative effectiveness trials
Ken Cheung
2016 (Montreal) Annual Meeting
Invited Session
Evaluating Precision Medicine in Clinical Trials
Andisheh Bakhshi
2016 (Montreal) Annual Meeting
Contributed Session
EVALUATION OF THE WORKING HEALTH SERVICE SCOTLAND
J. Michael Dean
2016 (Montreal) Annual Meeting
Invited Session
Evolution and Function of Clinical Research Networks: What drives success?
Marinella Temprosa
2016 (Montreal) Annual Meeting
Invited Session
Expanding Your Reach: Innovations and opportunities for remote participant visits to boost retention and enrollment in research studies
Thomas Jaki
2016 (Montreal) Annual Meeting
Contributed Session
Factorial versus multi-arm multi-stage designs in clinical trials
Amy Xia
2016 (Montreal) Annual Meeting
Invited Session
FDA IND Reporting Final Rule Compels a New Dialog among the DMC, Sponsor and FDA
Jennifer Mischke
2016 (Montreal) Annual Meeting
Contributed Session
FDA Pre-Submission Program Overview and How to Effectively use the Program to Move a Device to the US Market
Samantha Hinsley
2016 (Montreal) Annual Meeting
Contributed Session
FUTILITY ANALYSIS CONSIDERATIONS FOR A PHASE II TRIAL WITH SHORT TERM NON-INFERIORITY AND LONG TERM SUPERIORITY CO-PRIMARY ENDPOINTS
Jose-Miguel Yamal
2016 (Montreal) Annual Meeting
Contributed Session
Futility Trials Revisited: Do They Still Have a Place in Clinical Trial Research?
Lee McDaniel
2016 (Montreal) Annual Meeting
Contributed Session
Generating survival times to simulate additive hazards models
Toshimitsu Hamasaki
2016 (Montreal) Annual Meeting
Contributed Session
Group-sequential three-arm noninferiority clinical trial designs
Prof Jonathan Cook
2016 (Montreal) Annual Meeting
Invited Session
Guidance on specifying the target difference (“effect size”) for a RCT
Leila Rooshenas
2016 (Montreal) Annual Meeting
Contributed Session
HOW PRE-TRIAL RESEARCH CAN TRANSFORM PRE-SPECIFIED RANDOMISED CONTROLLED TRIAL DESIGN: A CASE STUDY AND IMPLICATIONS FOR FUTURE PRACTICE
David Beard
2016 (Montreal) Annual Meeting
Contributed Session
IMBALANCE IN RECRUITMENT BETWEEN SITES IN SURGICAL TRIALS: HOW PROBLEMATIC?
Jonathan Cook
2016 (Montreal) Annual Meeting
Contributed Session
IMPACT OF TIMING OF FOLLOW-UP UPON OUTCOME IN A SURGICAL TRIAL
Jennifer Gassman
2016 (Montreal) Annual Meeting
Contributed Session
Implementation of a three-stage recruitment tracking system in the Blood Pressure in Hemodialysis Pilot (BID) RCT comparing blood pressure level treatment arms
Carolyn Wilson
2016 (Montreal) Annual Meeting
Contributed Session
Implementation of a web-based screen failure log with real-time data collection and assessment facilitated timely modification of eligibility criteria in an adjuvant lung cancer immunotherapy trial
Wenle Zhao
2016 (Montreal) Annual Meeting
Contributed Session
IMPLEMENTATION OF BETTER AND SIMPLE ALTERNATIVES TO PERMUTED BLOCK DESIGN
Rebecca Lewis
2016 (Montreal) Annual Meeting
Contributed Session
Implementing Electronic Data Capture (EDC) – Lessons Learnt
Thomas Jemielita
2016 (Montreal) Annual Meeting
Contributed Session
Improved Power in Crossover Designs through Linear Combinations of Baselines
Akshata Ashokkumar
2016 (Montreal) Annual Meeting
Contributed Session
IMPROVING CLINICAL TRIAL EFFICIENCY: USE OF CENTRAL IRB AND MASTER TRIAL AGREEMENTS
Anne Duncan
2016 (Montreal) Annual Meeting
Contributed Session
Improving trial questionnaire response rates using behaviour change theory.
Peiyao Cheng
2016 (Montreal) Annual Meeting
Contributed Session
INCREASE THE PRECISION OF EFFECT SIZE ESTIMATE IN TIME TO EVENT DATA WITH INTERVAL CENSORING USING UNBALANCED DESIGN
Robert Lindblad, MD
2016 (Montreal) Annual Meeting
Invited Session
Initiating a Clinical Trial in an Epidemic Hot Zone; The Sierra Leone Ebola Experience
Haitao Pan
2016 (Montreal) Annual Meeting
Invited Session
Innovative Trial Designs for Precision Medicine
Judy Needham
2016 (Montreal) Annual Meeting
Contributed Session
Integrating Patient / Public Involvement in the NCIC Clinical Trials Group
Chris Cook
2016 (Montreal) Annual Meeting
Contributed Session
INTEGRATING TRADITIONAL ELECTRONIC DATA CAPTURE (EDC) WITH NEW SYSTEMS
Victoria Borg Debono
2016 (Montreal) Annual Meeting
Contributed Session
INTERIM DATA SHARING; WHAT INTERIM RESULTS OR INFORMATION SHOULD OR SHOULDN'T BE SHARED DURING THE INTERIM OF A RANDOMIZED CONTROLLED TRIAL WITH THOSE RESPONSIBLE FOR THE CONDUCT OF THE TRIAL?
Fangxin Hong
2016 (Montreal) Annual Meeting
Invited Session
Interim monitoring for clinical trials: then and now
Koko Asakura
2016 (Montreal) Annual Meeting
Contributed Session
Interim monitoring of clinical trials with co-primary endpoints using predicted intervals
Neal Oden
2016 (Montreal) Annual Meeting
Contributed Session
Interim Monitoring of Non-inferiority Trials
Norma Diaz-Mayoral
2016 (Montreal) Annual Meeting
Contributed Session
INVENTORY MANAGEMENT: UTILIZATION OF THE BSI SYSTEM TO INTEGRATE SPECIMEN-RELATED DATA
Andrew Cook
2016 (Montreal) Annual Meeting
Contributed Session
Involving Clinical Experts in Prioritising Topics for Pragmatic Trials: A Factorial Randomised Controlled Trial
Paul Brocklehurst
2016 (Montreal) Annual Meeting
Contributed Session
It is not all about effectiveness. The use of efficiency measures in evaluative designs.
Todd MacKenzie
2016 (Montreal) Annual Meeting
Invited Session
Joint modeling in clinical trials
Julie Croft
2016 (Montreal) Annual Meeting
Contributed Session
Key Trial & Data Management Considerations for Planning Surgical Trials
Annabelle South (TBC)
2016 (Montreal) Annual Meeting
Invited Session
Knowledge translation for clinical trials: experiences from trials in Canada, the UK and Africa
Marina Djurfeldt
2016 (Montreal) Annual Meeting
Contributed Session
LAUNCHING THE CANADIAN CANCER TRIALS GROUP SITE TRAINING INITIATIVE
Lauren Yesko
2016 (Montreal) Annual Meeting
Contributed Session
Lessons Learned In Collecting Participant Reported Outcome Data via Web-Based Data Systems
Ruiqi Zhang
2016 (Montreal) Annual Meeting
Contributed Session
Long term follow-up in randomised trials with delayed intervention for the control group
Brenda Kurland
2016 (Montreal) Annual Meeting
Invited Session
Low Dose Computed Tomography (LDCT) screening for lung cancer: Opportunities for refinement using quantitative imaging biomarkers
Rebecca Neiberg
2016 (Montreal) Annual Meeting
Contributed Session
MANAGING DATA QUALITY OF PARTICIPANT WEIGHTS UPLOADED FROM SMART SCALES: THE STUDY OF NOVEL APPROACHES TO PREVENTION CLINICAL TRIAL – EXTENSION PHASE
Julian Wolfson
2016 (Montreal) Annual Meeting
Contributed Session
Matching-based sensitivity analysis for assessing mediation in randomized trials
Annabelle South
2016 (Montreal) Annual Meeting
Contributed Session
Measuring the impact of clinical trials: developing and applying a set of impact metrics
Jeannette Lee
2016 (Montreal) Annual Meeting
Contributed Session
MEDICATION ADHERENCE IN A STUDY TO PREVENT VAGINAL INFECTIONS
Matthew Sims
2016 (Montreal) Annual Meeting
Contributed Session
METHODLOGICAL QUALITY AND RISK OF BIAS ASSESSMENTS IN ORTHOPEDIC SURGERY SYSTEMATIC REVIEWS
Leila Rooshenas
2016 (Montreal) Annual Meeting
Contributed Session
METHODS FOR SELECTING HEALTH CONCEPTS AND DOMAINS FOR THE DEVELOPMENT OF PATIENT REPORTED OUTCOME MEASURES (PROMS): A CASE STUDY
Patricia Feeney
2016 (Montreal) Annual Meeting
Contributed Session
Methods to minimize bias during the analysis of open-label, randomized controlled trials
Tolulope Sajobi
2016 (Montreal) Annual Meeting
Contributed Session
Minimal Sufficient Balance Randomization for Endovascular Stroke Trials: Results from the ESCAPE trial
Marion Campbell
2016 (Montreal) Annual Meeting
Contributed Session
Missing data matter: should trials routinely report their Fragility Index?
Karla Hemming
2016 (Montreal) Annual Meeting
Contributed Session
MODELLING DIFFERENTIAL CLUSTERING AND TREATMENT EFFECT HETEROGENEITY IN PARALLEL AND STEPPED WEDGE CLUSTER RANDOMISED TRIALS
Annabelle South
2016 (Montreal) Annual Meeting
Contributed Session
Models and impact of patient and public involvement in studies carried out by the MRC Clinical Trials Unit at UCL: Findings from 10 case studies
Anne Hoehn
2016 (Montreal) Annual Meeting
Contributed Session
Monitoring Medication Adherence Using a Mobicontrol Application: A Case Study
Suzanne Breeman
2016 (Montreal) Annual Meeting
Contributed Session
MULTI-ARM RANDOMISED CONTROLLED TRIALS: A TRIAL MANAGERS PERSPECTIVE
Claire Cochran
2016 (Montreal) Annual Meeting
Contributed Session
Negotiating hurdles, providing solutions to problems; Sharing the Challenges and lessons of managing a seven year International RCT
Rick Chappell
2016 (Montreal) Annual Meeting
Contributed Session
Null Hypothesis Scales in Non-Inferiority Trials
Catherine Klersy
2016 (Montreal) Annual Meeting
Contributed Session
One size does not fit all: adherence to STROBE guidelines in sample size calculations from the perspective of an Ethical Committee
Andrew Forbes
2016 (Montreal) Annual Meeting
Contributed Session
Optimal allocation in stepped wedge designs
Rachael Williams
2016 (Montreal) Annual Meeting
Contributed Session
Optimising the drug development pathway and life cycle management through the integration of observational and interventional data and expertise
Bray Patrick-Lake
2016 (Montreal) Annual Meeting
Invited Session
Overcoming Barriers to Effective Research Partnerships with Patient Groups
William Meurer, MD, MS
2016 (Montreal) Annual Meeting
Invited Session
Partnering biostatisticians and clinicians to train the next generation of neurological clinical trialists: the National Institutes of Neurological Disorders and Stroke Clinical Trials Methodology Course (NINDS-CTMC)
Gail McDonald
2016 (Montreal) Annual Meeting
Contributed Session
Patient Retention in Clinical Trials – The Canadian Cancer Trials Group (CCTG) Group Experience with Withdrawal of Consent and Lost to Follow Up
Agnieshka Baumritter
2016 (Montreal) Annual Meeting
Contributed Session
Pilot Study of a Tiered Approach to ROP Screening (TARP) using a Weight Gain Predictive Model and a Telemedicine System
Janet Holbrook
2016 (Montreal) Annual Meeting
Contributed Session
PLACEBOS ARE MORE EFFECTIVE IN WOMEN THAN MEN WITH ASTHMA
Adrian Hernandez
2016 (Montreal) Annual Meeting
Invited Session
Planning for the Future – Expanding Opportunities for Pragmatic Trials
Hongsheng Wu
2016 (Montreal) Annual Meeting
Contributed Session
Power Calculation for stepped wedge designs with pre-post evaluations
Shun Fu Lee
2016 (Montreal) Annual Meeting
Contributed Session
Power of the adjusted Q statistic for the meta-analysis of cluster randomization trials.
Robert Lindblad, MD
2016 (Montreal) Annual Meeting
Invited Session
Practical Experiences facilitating the use of “BIG” Health Care Clinical Data to Conduct Clinical Research
Chad Winch
2016 (Montreal) Annual Meeting
Contributed Session
PRACTICAL IMPLEMENTATION OF AN ADAPTIVE CLINICAL TRIAL DESIGN IN A MULTI-STAGE RANDOMIZED PHASE II STUDY OF NOVEL COMBINATION THERAPY FOR THE TREATMENT OF RELAPSED AND REFRACTORY AGGRESSIVE B-CELL LYMPHOMA: CANADIAN CANCER TRIALS GROUP LY.17
Scott Evans
2016 (Montreal) Annual Meeting
Invited Session
Pragmatic Trials
Nicola Soriani
2016 (Montreal) Annual Meeting
Contributed Session
PREDICTING OUTCOMES IN A CLINICAL TRIAL: A SUPER LEARNER APPROACH
TINGTING LI
2016 (Montreal) Annual Meeting
Contributed Session
Presenting Interim Clinical Trial Data for Decision Makers with Diverse Backgrounds
Bray Patrick-Lake
2016 (Montreal) Annual Meeting
Invited Session
Proactively Addressing Enrollment Challenges – CTTI’s Recommendations for Improving Recruitment Planning and Informed Consent
Nicola Greenlaw
2016 (Montreal) Annual Meeting
Contributed Session
Problems, solutions and challenges using routinely collected prescription dispensing data in a randomized controlled trial setting
Lynda Ugwu
2016 (Montreal) Annual Meeting
Invited Session
Prospective Individual Participant Data Meta-Analysis
Jennifer Snyder
2016 (Montreal) Annual Meeting
Contributed Session
Provincial Centralized Research Ethics Boards: How a Canadian Clinical Trial Sponsor Supports the Quebec Model
Alexander Demand
2016 (Montreal) Annual Meeting
Contributed Session
Publication Bias and Non-Reporting Found in Majority of Systematic Reviews and Meta-Analyses in Anesthesiology Journals
Cole Wayant
2016 (Montreal) Annual Meeting
Contributed Session
Publication bias evaluations are not routinely conducted in clinical oncology systematic reviews
Susan Kunselman
2016 (Montreal) Annual Meeting
Contributed Session
QUALITY ASSURANCE PROCESSES FOR PULMONARY FUNCTION TESTS IN AN ASTHMA CLINICAL TRIAL: THE ASTHMANET BARD TRIAL
Tracey Serpi
2016 (Montreal) Annual Meeting
Contributed Session
Quality Studies: Using Risk Based Monitoring in the Department of Veterans Affairs Cooperative Studies Program to Enhance Human Subject Protection and Data Integrity
Catherine Oldenburg
2016 (Montreal) Annual Meeting
Contributed Session
RANDOMIZED BY NATURE: CLINICAL TRIALS WITH THRESHOLD TREATMENT ASSIGNMENT
Larisa Tereshchenko
2016 (Montreal) Annual Meeting
Contributed Session
Randomized Controlled Trial Adaptive CRT effect on ELectrical dysSYNChrony (aCRT ELSYNC): study design
Pamela Shaw
2016 (Montreal) Annual Meeting
Invited Session
Randomized controlled trials of behavior economics interventions: Examples and considerations for design
Dave DeMets
2016 (Montreal) Annual Meeting
Contributed Session
Recommendations from the Clinical Trials Transformation Initiative Data Monitoring Committee Project
David DeMets
2016 (Montreal) Annual Meeting
Invited Session
Recommendations from the Clinical Trials Transformation Initiative Data Monitoring Committee Project
Dena Howard
2016 (Montreal) Annual Meeting
Contributed Session
Recommendations on multiple-testing adjustment in multi-arm trials with correlated hypotheses
Safawa Huq
2016 (Montreal) Annual Meeting
Contributed Session
Recruitment Strategies Implemented in the “B Cell Targeted Treatment in Myasthenia Gravis (BeatMG)” Trial: Understanding the Approach to Successful Recruitment for a Rare Disease Population Utilizing a Clinical Trial Network
Aenne Glass
2016 (Montreal) Annual Meeting
Contributed Session
REDUCTION OF RADIATION EXPOSURE DURING ABLATION OF ATRIAL FIBRILLATION
Marc Schwartz
2016 (Montreal) Annual Meeting
Contributed Session
Reproducible Research and Dynamically Generated Biostatistical Analyses
Radhika Kondapaka
2016 (Montreal) Annual Meeting
Contributed Session
RESOLUTION OF ADVERSE EVENTS: DISCUSSION OF INNOVATIVE SOLUTIONS
Katie Gillies
2016 (Montreal) Annual Meeting
Contributed Session
Retention in randomised trials: What matters to Trial Managers?
Caroline Hurley
2016 (Montreal) Annual Meeting
Contributed Session
Risk assessment tools for clinical trial monitoring: a systematic review
Amparo Casanova
2016 (Montreal) Annual Meeting
Contributed Session
SAMPLE SIZE CALCULATIONS FOR CLUSTER CROSSOVER RANDOMIZED TRIALS
Brittany Schwefel
2016 (Montreal) Annual Meeting
Contributed Session
Sample Size Re-estimation of Event-Driven Trials with Composite Events and Delayed Data Ascertainment
Laura Smeaton
2016 (Montreal) Annual Meeting
Contributed Session
SCREENING AND ENROLLMENT BY SEX IN HIV CLINICAL TRIALS – A CROSS-PROTOCOL ANALYSIS
Lucille Sebastian
2016 (Montreal) Annual Meeting
Contributed Session
Screening logs – opportunities and cautions for central monitoring
Gui-shuang Ying
2016 (Montreal) Annual Meeting
Contributed Session
SECONDARY ANALYSIS of CLINICAL TRIALS DATA – A BIOSTATISTICIAN’S EXPERIENCE
Andres Tellez
2016 (Montreal) Annual Meeting
Contributed Session
Selective Withdrawal in an Open Label Clinical Trial: CRLX101 in Non-Small Cell Lung Cancer
Hwasoon Kim
2016 (Montreal) Annual Meeting
Contributed Session
Simulation Study for Sample Size Re-Estimation Methods Based on Log-Rank Statistics for Non-Inferiority Studies with Censored Survival Data
Dario Gregori
2016 (Montreal) Annual Meeting
Contributed Session
Some insights in setting non-inferiority margin when information is available on the trial arms effects
Soeun Kim
2016 (Montreal) Annual Meeting
Contributed Session
Standardized Global Statistical Test for Combining Multiple Outcomes in Clinical Trials
Zhibao Mi
2016 (Montreal) Annual Meeting
Contributed Session
Statistical Assessment and Adjustment of Imbalance Caused Biased Treatment Effect
Rosemarie Mick
2016 (Montreal) Annual Meeting
Invited Session
Statistical Challenges in Immuno-Oncology
Emmanuel Sampene
2016 (Montreal) Annual Meeting
Contributed Session
Statistical Inference in Randomized Consent Designs in the Presence of Hawthorne Effects
Anne Lindblad
2016 (Montreal) Annual Meeting
Contributed Session
STATISTICAL MONITORING IN CLINICAL TRIALS: AN EXPERIMENT TO DETECT FABRICATED DATA
Ranran Dong
2016 (Montreal) Annual Meeting
Contributed Session
Stepped Wedge Cluster Randomized Controlled Trials with Two Layers of Clustering: Designs and Comparisons of Power
Amber Randall
2016 (Montreal) Annual Meeting
Contributed Session
Strategic Considerations for CDISC Implementation
Cindy Jacobson
2016 (Montreal) Annual Meeting
Contributed Session
STRATEGIES IMPLEMENTED FOR OPTIMIZED DISPENSING OF AN INVESTIGATIONAL NEW DRUG DELIVERY DEVICE IN A MULTI-SITE HIV PREVENTION CLINICAL TRIAL
Lynda Constable
2016 (Montreal) Annual Meeting
Contributed Session
Strategies to improve recruitment in surgical trials: targeting patient and clinical preferences
Briana Cameron
2016 (Montreal) Annual Meeting
Contributed Session
Stratification in the two-stage randomized trial design for testing treatment, self-selection, and treatment preference effects
Pamela Tenaerts
2016 (Montreal) Annual Meeting
Invited Session
Streamlining Clinical Trials: Putting Words into Action
John Alexander
2016 (Montreal) Annual Meeting
Invited Session
Streamlining clinical trials: the practicalities
Susanna Jacobus
2016 (Montreal) Annual Meeting
Invited Session
Strengthening the Oncology Cooperative Group Community-Based Clinical Research Enterprise
Elizabeth Avery
2016 (Montreal) Annual Meeting
Contributed Session
STUDY AND DATA MANAGEMENT OF A CHURCH BASED CBPR INTERVENTION DEVELOPMENT PROJECT: LESSONS LEARNED
Elias Klemperer
2016 (Montreal) Annual Meeting
Contributed Session
Study characteristics account for the majority of variance in clinical trials of medications for alcohol use disorders: A meta-analysis
Nigel Scott
2016 (Montreal) Annual Meeting
Contributed Session
STUDY DRUG MANAGEMENT SYSTEM WITHIN AN INTERNATIONAL TRIALS CONSORTIUM
Katelyn Garcia
2016 (Montreal) Annual Meeting
Contributed Session
SUSPENSION AND INTERVENTION MODIFICATION FOR PREGNANCIES IN A WEIGHT GAIN PREVENTION TRIAL: THE STUDY OF NOVEL APPROACHES TO PREVENTION CLINICAL TRIAL
Shokoufeh Khalatbari
2016 (Montreal) Annual Meeting
Contributed Session
TATUM: A WEB-BASED TOOL FOR OBTAINING A TREATMENT ALLOCATION IN A RANDOMIZED CONTROLLED CLINICAL TRIAL WITH A BUILT IN TRACKING SYSTEM FOR THE MANAGEMENT OF THE RANDOMIZATION PROCESS
Michaela Goodwin
2016 (Montreal) Annual Meeting
Contributed Session
Testing methods to increase response to questionnaires in a longitudinal study
Luigia Scudeller
2016 (Montreal) Annual Meeting
Contributed Session
The BISON (Bloodstream Infections and Sepsis Outcomes measurement Network) initiative: systematic overview of outcomes used in systematic reviews on interventions for sepsis and/or bloodstream infections
Valeria Musella
2016 (Montreal) Annual Meeting
Contributed Session
The challenge of electronic case report form in investigators-initiated studies
Pamela Tenaerts, MD, MBA
2016 (Montreal) Annual Meeting
Contributed Session
The Clinical Trials Transformation Initiative: Improving the Quality and Efficiency of Clinical Trials
Eve Jelstrom
2016 (Montreal) Annual Meeting
Contributed Session
THE CREATION, DEVELOPMENT AND USE OF AN ELECTRONIC SITE VISIT REPORT
Ines Rombach
2016 (Montreal) Annual Meeting
Contributed Session
THE CURRENT PRACTICE OF HANDLING AND REPORTING MISSING OUTCOME DATA IN 8 WIDELY-USED PATIENT REPORTED OUTCOME MEASURES IN PUBLICATIONS OF RANDOMIZED CONTROLLED TRIALS: A REVIEW OF THE CURRENT LITERATURE
Rebecca Elmore
2016 (Montreal) Annual Meeting
Contributed Session
THE ENVIRONMENTAL POLYMORPHISMS REGISTRY (EPR): A RESOURCE TO FACILITATE RECRUITMENT FOR CLINICAL STUDIES
Cory Goldstein
2016 (Montreal) Annual Meeting
Contributed Session
THE ETHICS OF PRAGMATIC RANDOMIZED CONTROLLED TRIALS IN COMPARATIVE EFFECTIVENESS RESEARCH
Simon Bacon
2016 (Montreal) Annual Meeting
Invited Session
The International Behavioural Trials Network (IBTN): An International effort to improve the rigor and impact of behavioral clinical trials
Norma Diaz-Mayoral
2016 (Montreal) Annual Meeting
Contributed Session
THE RELOCATION OF A SPECIMEN COLLECTION: COORDINATION OF LOGISTICS, SELECTING THE RIGHT PACKAGING, DATA MAPPING AND LESSONS LEARNED
William Coar
2016 (Montreal) Annual Meeting
Contributed Session
The Right Time to Implement CDISC
Rui (Sammi ) Tang
2016 (Montreal) Annual Meeting
Invited Session
The Statistical Challenges in Recent Development of Personalized Medicine – through biomarker subgroup identification to companion diagnostic device development
Karla Hemming
2016 (Montreal) Annual Meeting
Invited Session
The stepped wedge cluster randomised trial – design and analysis and current challenges
Navneet Hakhu
2016 (Montreal) Annual Meeting
Contributed Session
THE THREE PILLARS OF A SUCCESSFUL DATA MONITORING COMMITTEE ORGANIZATIONAL MEETING AND INTERIM MONITORING OF A RANDOMIZED CLINICAL TRIAL
Kevin Wilson
2016 (Montreal) Annual Meeting
Contributed Session
The Use of Data Visualization Tools to Monitor Key Clinical Trial Activities
Joseph Ross
2016 (Montreal) Annual Meeting
Contributed Session
The Yale Open Data Access (YODA) Project: Lessons Learned in Clinical Trial Data Sharing
Shaun Treweek
2016 (Montreal) Annual Meeting
Contributed Session
Time well spent? A comparison of the work associated with collecting primary and secondary outcomes.
Graham Quinn
2016 (Montreal) Annual Meeting
Contributed Session
Timely implementation of an ROP Telemedicine System
Roger Lewis, MD, PhD
2016 (Montreal) Annual Meeting
Invited Session
Training academic clinicians and biostatisticians to design and simulate adaptive clinical trials: the National Institutes of Neurological Disorders and Stroke Clinical Trials Methodology Advanced Course
Wendy Parulekar
2016 (Montreal) Annual Meeting
Invited Session
Translational scientists/ Bioinformaticians and Biostatisicians – Menage a Trois or Melange a Trois
Natalie Blencowe
2016 (Montreal) Annual Meeting
Contributed Session
Uncovering the influence of performance bias: a methodological study nested within an RCT
Wendy Parulekar
2016 (Montreal) Annual Meeting
Invited Session
Use of administrative and registry data in clinical trials
Dikla Blumberg
2016 (Montreal) Annual Meeting
Contributed Session
USE OF CERTIFICATES OF CONFIDENTIALITY TO PROTECT RESEARCH PARTICIPANTS’ PRIVACY IN RESPONSE TO LEGAL DEMANDS
Ashley Case
2016 (Montreal) Annual Meeting
Contributed Session
Use of EDC Systems to Monitor Informed Contents Remotely
Lisa A. Marsch, PhD and Carmen Rosa, MS
2016 (Montreal) Annual Meeting
Invited Session
Use of Mobile Health Technologies in Pragmatic Clinical Trials
Paul VanVeldhuisen, PhD
2016 (Montreal) Annual Meeting
Invited Session
Using “BIG” Health Care Clinical Data to Conduct Clinical Research
Stephanie DuBose
2016 (Montreal) Annual Meeting
Contributed Session
USING A PATIENT REGISTRY TO CONDUCT NON-CLINIC ENGAGED STUDIES
Scott Evans
2016 (Montreal) Annual Meeting
Contributed Session
USING ENDPOINTS TO ANALYZE PATIENTS RATHER THAN PATIENTS TO ANALYZE ENDPOINTS: A PRE-TRIAL SUBSTUDY TO DEVELOP A GLOBAL OUTCOME FOR CLINICAL TRIALS
Matthias Pierce
2016 (Montreal) Annual Meeting
Contributed Session
Using trials to identify personalised treatment rules
Thuong La
2016 (Montreal) Annual Meeting
Contributed Session
Utilizing cloud-based file synchronization platform for real-time data transfer, central storage and collaboration network
Kirsty Loudon
2016 (Montreal) Annual Meeting
Contributed Session
Validity and Reliability of PRECIS-2 – a tool designed to help trialists match their trial design decisions to the needs of those they hope will use the results
Lucille Sebastian
2016 (Montreal) Annual Meeting
Contributed Session
Variation in routine follow up for preterm babies: implications for clinical trials
Loretta Davies
2016 (Montreal) Annual Meeting
Contributed Session
WHAT CAN WE LEARN FROM EXPERIENCE? IMPACT OF HEALTHCARE PROVIDER EFFECTS IN THE TOTAL OR PARTIAL KNEE ARTHROPLASTY TRIAL (TOPKAT)
TBC
2016 (Montreal) Annual Meeting
Invited Session
What happens when a trial is interrupted? How to deal with suspension of randomisation and restart your trial
Kerry Avery
2016 (Montreal) Annual Meeting
Contributed Session
What is the effect of item order (patient reported outcomes first or last?) in a questionnaire on the measurement and prioritisation of outcomes: a randomised controlled trial
Todd MacKenzie
2016 (Montreal) Annual Meeting
Contributed Session
Who Are the Compliers? Reporting Baseline Characteristics to Accompany the Causal Effect of Treatment